Contract Manufacturing Organizations (CMOs) are manufacturing companies that produce drugs, medical devices, and Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies.
Goto Lianhe Aigen to know more.
The pharmaceutical CMOs market was valued at US$98,487 million in and is expected to grow at a CAGR of 6.9% from -. This article outlines why pharmaceutical companies are increasingly outsourcing production to CMOs, lists associated industry benefits, and provides a market outlook.
MedicaPharma ensures access to GMP active pharmaceutical ingredients across multiple resilient global supply chains. Click here to view a full GMP API product list.
MedicaPharma is capable of supplying all GMP materials needed; our experience with sourcing materials that are difficult to obtain makes us the ultimate choice; just challenge us, we will find any material you need.
Add your Chemical Name below and click GO!
Sourcing pharmaceutical materials can be challenging for some companies, mainly when specific pharmaceutical ingredients are unavailable or cost-intensive. CMOs help streamline the drug production process, allowing pharmaceutical companies to focus on research and development.
Other benefits of contracting production to CMOs include:
CMOs usually manufacture drugs that have been developed by biotech firms or pharmaceutical companies and approved by regulatory bodies. However, CMOs may also produce pharmaceutical products currently unavailable for several reasons, including those still undergoing clinical trials.
4. CMOs can help ensure regulatory compliance.
CMOs typically have strict quality control procedures in place, producing APIs to high standards in accordance with Good Manufacturing Practices (GMP).
Contracting API production to CMOs can help pharmaceutical companies bring drugs to market quickly. CMOs typically achieve faster manufacturing by leveraging streamlined processes and economies of scale when compared to in-house manufacturing.
For more GMP Manufacturerinformation, please contact us. We will provide professional answers.
CMOs manufacture a wide range of pharmaceutical products, including:
APIs refer to one or more active substances within a drug, while the drug is the final product administered to the consumer.
Pharmaceutical intermediates are chemical compounds synthesized during the API manufacturing process.
Intermediates are not intended for final use by consumers, but are essential components that are subjected to additional processing to manufacture the API. In contrast, APIs are biologically active compounds associated with the effect of the drug.
According to the Milan-based Chemical Pharmaceutical Association (CPA), the World Pharmaceutical Contract Research and Manufacturing Services (PCRAMS) industry is growing rapidly.
The association recently released a report claiming that revenues rose 10.8% on average every year to reach $70 billion in . Regions of focus include China with 26% year-over-year growth, and India.
Recent research by Visiongain reveals that the CMO industry is expected to grow at a CAGR of 6.9% from -. According to the report, growth is catalyzed by technological innovation, specifically data integration across multiple systems, data repositories that provide insights into drug performance, and software applications that improve trial design.
Are you looking for a cost effective solution of GMP (Good Manufacturing Practice) audits reports?
In our database, we now show possibilities where to purchase independent GMP audit reports, at which producing companies an audit is planned, or where a shared audit report can be inquired.
Why not save time and money with buying an existing audit report or participate in a shared audit?
Simply go to ‘Find APIs’ type in the API in question and check for the available auditor information on the right side.
If you want to learn more, please visit our website Drug Substance CDMO Service.